کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
2493202 1556631 2014 8 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Impact of in vivo chronic blockade of adenosine A2A receptors on the BDNF-mediated facilitation of LTP
موضوعات مرتبط
علوم زیستی و بیوفناوری علم عصب شناسی علوم اعصاب رفتاری
پیش نمایش صفحه اول مقاله
Impact of in vivo chronic blockade of adenosine A2A receptors on the BDNF-mediated facilitation of LTP
چکیده انگلیسی


• Chronic in-vivo blockade of A2AR abolishes BDNF effects upon hippocampal CA1 LTP.
• Activation of A2AR after chronic blockade does not restore BDNF effects upon LTP.
• Chronic blockade of A2AR reduces mRNA and protein levels of TrkB-FL receptor.

Brain-derived neurotrophic factor (BDNF) through the activation of its receptor (TrkB-FL) exert well-described neuroprotective effects playing a major role in hippocampal synaptic transmission and plasticity such as long-term potentiation (LTP), a molecular surrogate for learning and memory. Impairments in BDNF signalling have been associated to several neurodegenerative disorders such as Alzheimer's disease (AD). Therefore, the reestablishment of BDNF actions is considered a promising strategy for AD treatment. While, most of BDNF synaptic actions, namely on LTP, require the activation of adenosine A2A receptor (A2AR), the antagonists of A2AR have been proven to prevent AD induced deficits in different animal models. Therefore in this work we aimed to evaluate the impact of a chronic in vivo oral administration of an A2AR antagonist (KW-6002) in the BDNF actions upon hippocampal CA1 LTP.The results showed that chronic blockade of A2AR in male Wistar rats inhibits the facilitatory action of BDNF upon LTP on hippocampal CA1 area and decreases both mRNA and protein levels of the TrkB-FL receptor in hippocampus. These findings imply that BDNF signalling may be affected in chronic A2AR blocking conditions.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Neuropharmacology - Volume 83, August 2014, Pages 99–106
نویسندگان
, , , , , , ,